Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung Cancer
PaperCitations, authors & open-access status
First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,092 citations, 2020 year and bronze oa status.
1,092
Citations
2020
Year
bronze
OA Status